A common MET polymorphism harnesses HER2 signaling to drive aggressive squamous cell carcinoma.
Kong LR, Mohamed Salleh NAB, Ong RW, Tan TZ, Syn NL, Goh RM, Fhu CW, Tan DSW, Iyer NG, Kannan S, Verma CS, Lim YC, Soo R, Ho J, Huang Y, Lim JSJ, Yan BJ, Nga ME, Lim SG, Koeffler HP, Lee SC, Kappei D, Hung HT, Goh BC.
Kong LR, et al. Among authors: syn nl.
Nat Commun. 2020 Mar 25;11(1):1556. doi: 10.1038/s41467-020-15318-5.
Nat Commun. 2020.
PMID: 32214092
Free PMC article.